Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 138 member D (FAM138D) is a gene encoding a putative 85-amino acid polypeptide, also referred to as F379 retina-specific protein[2][3][6]. This gene was initially identified as being specifically expressed in the human retina, mapped to subtelomeric regions of multiple chromosomes, and appears to be duplicated in a polymorphic manner[2]. The protein does not show significant homology to known functional protein domains or established molecular families outside of sequence elements (Alu and MIR repeats) and currently has no confirmed known biological function, disease association, or therapeutic targeting role[2][3][6][8]. Its naming and expression profile support a role as a retina-specific gene, but current literature and databases offer no evidence of involvement in any major molecular pathways, no identified small molecule or therapeutic interactions, and it is not classified as an established target for drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 138 member D (FAM138D).